Inpatient Hospital Costs for COVID-19 Patients in the United States

被引:0
作者
Robert L. Ohsfeldt
Casey Kar-Chan Choong
Patrick L. Mc Collam
Hamed Abedtash
Kari A. Kelton
Russel Burge
机构
[1] Texas A&M University,
[2] Eli Lilly and Company,undefined
[3] Medical Decision Modeling Inc.,undefined
[4] GPORWE-Bio-Medicines,undefined
[5] Eli Lilly and Company,undefined
[6] University of Cincinnati,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
COVID-19; Hospital costs; Intensive care unit (ICU); Length of stay; Post-acute care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5557 / 5595
页数:38
相关论文
共 48 条
[1]  
Nicola M(2020)The socio-economic implications of the coronavirus pandemic (COVID-19): a review Int J Surg 78 185-193
[2]  
Alsafi Z(2020)Assessing the impact of neighborhood socioeconomic characteristics on COVID-19 prevalence across seven states in the United States Front Public Health 8 571808-1217
[3]  
Sohrabi C(2020)Disease and healthcare burden of COVID-19 in the United States Nat Med 26 1212-4995
[4]  
Hatef E(2020)Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey Crit Care 24 516-935
[5]  
Chang H-Y(2020)Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis Crit Care 24 389-317
[6]  
Kitchen C(2020)Baseline demographics and clinical characteristics among 3471 US patients hospitalized with COVID-19 and pulmonary involvement: a retrospective study Adv Ther 37 4981-2554
[7]  
Weiner JP(2020)The potential health care costs and resource use associated with COVID-19 in the United States Health Aff (Millwood) 39 927-1826
[8]  
Kharrazi H(2021)Health outcomes and economic burden of hospitalized COVID-19 patients in the United States J Med Econ 24 308-807
[9]  
Miller IF(2020)Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations JAMA 324 2553-1699
[10]  
Becker AD(2020)Remdesivir for the treatment of Covid-19—final report N Engl J Med 383 1813-undefined